Isolation and application of BAD-1 for diagnosing infections with
Methods for obtaining highly pure native, recombinant or modified BAD-1 protein include the steps of culturing a population of microbes expressing BAD-1 protein in a culture medium, collecting the population of microbes from the culture medium, obtaining a BAD-1 protein-containing solution, and purifying the BAD-1 protein from the solution by combining the BAD-1 protein-containing solution with a nickel-chelating resin, washing the nickel-chelating resin to remove unbound matter, and eluting the BAD-1 protein from the nickel-chelating resin. Highly pure native BAD-1 protein may be used in diagnostic kits for detecting Blastomyces dermatitidis infections in animals.
1. A method for the purification of native Blastomyces Adhesion 1 (BAD-1) protein or protein fragments, comprising the steps of:
(a) obtaining a native BAD-1 protein or protein fragment-containing solution; and
(b) purifying the native BAD-1 protein or protein fragments from the solution in the absence of affinity tags, consisting essentially of the steps of:
(i) combining the native BAD-1 protein or protein fragments-containing solution with a suitable divalent cation,
(ii) washing the suitable divalent cation with an imidazole-free buffer to remove unbound matter, and
(iii) eluting the native BAD-1 protein or protein fragments with an imidazole-containing buffer from a nickel-chelating resin.
2. The method of claim 1 , wherein the native BAD-1 protein or protein fragment-containing solution is obtained by the steps of:
(a1) culturing a population of microbes expressing native BAD-1 protein or protein fragment in a culture medium;
(a2) collecting the population of microbes containing the native BAD-1 protein or protein fragment from the culture medium, and
(a3) isolating the native BAD-1 protein or protein fragment from the microbes.
3. The method of claim 1 , wherein the suitable divalent cation is a nickel-chelating resin.
4. The method of claim 2 , wherein the microbes comprise Blastomyces dermatitidis.
5. The method of claim 4 , wherein Blastomyces dermatitidis is selected from the group consisting of ATCC native strains of 26199, 14081, and ER-3.
6. The method of claim 1 , wherein step (a) comprises extraction of the BAD-1 protein or protein fragments from yeast cell surfaces using a low osmotic strength and divalent cation-free buffer.
7. The method of claim 1 , wherein the BAD-1 protein fragments are derived from one or more recombinant BAD-1 proteins.
8. A method for the purification of native Blastomyces Adhesion 1 (BAD-1) protein or protein fragments, comprising the steps of:
(a) obtaining a native BAD-1 protein or protein fragment-containing solution; and
(b) purifying the native BAD-1 protein or protein fragments from the solution in the absence of affinity tags, consisting essentially of the steps of:
(i) combining the native BAD-1 protein or protein fragments-containing solution with a suitable divalent cation,
(ii) washing the suitable divalent cation with an imidazole-free buffer to remove unbound matter, and
(iii) eluting the native BAD-1 protein or protein fragments with an imidazole-containing buffer from a nickel-chelating resin,
(iv) extracting contaminating mannoproteins from the eluted native BAD-1 protein or protein fragments.
9. A method for the purification of native Blastomyces Adhesion 1 (BAD-1) protein or protein fragments, comprising the steps of:
(a) obtaining a native BAD-1 protein or protein fragment-containing solution; and
(b) purifying the native BAD-1 protein or protein fragments from the solution in the absence of affinity tags, consisting essentially of the steps of:
(i) combining the native BAD-1 protein or protein fragments-containing solution with a suitable divalent cation,
(ii) washing the suitable divalent cation with an imidazole-free buffer to remove unbound matter, and
(iii) eluting the native BAD-1 protein or protein fragments with an imidazole-containing buffer from a nickel-chelating resin,
(iv) extracting contaminating mannoproteins from the eluted native BAD-1 protein or protein fragments by treating the eluted native BAD-1 protein or protein fragments with concanavalin-agarose resin.